CORTNasdaq United States
Market cap
$11.974 B
$110.77 +2.61%
Close of 7 Aug 2026
Revenue
$761.4M
#1683 by revenue
Earnings
$99.7M
#1318 by earnings
Shares outstanding
108,098,397
Latest filing cover page
P/E ratio
120.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Corcept Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.